Skip to content

Sea Buckthorn Aqueous Infusion Impact

Sea Buckthorn Aqueous Infusion Impact on Body Composition Metrics Among Overweight Female Adults.

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07313423
Acronym
Sbaii
Enrollment
60
Registered
2026-01-02
Start date
2026-01-01
Completion date
2026-04-15
Last updated
2026-01-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body Compostition

Keywords

sea buckthorn, aqueous infusion, body composition

Brief summary

* A total of 60 overweight women (BMI 25-29.9 kg/m²), aged 18-50years, will be enrolled and randomized equally into intervention and control groups. The intervention group will consume a 5 g freshly prepared seabuckthorn aqueous infusion daily for 12 weeks, while controls maintain usual habits without supplementation. * The seabuckthorn aqueous infusion will be prepared by using 250mL of potable boiled water and then cooled to a lukewarm temperature (around 40-45°C). At this point, 5 g of seabuckthorn powder will be added, stirred thoroughly until fully dispersed, and consumed immediately. The infusion will be freshly prepared once daily and administered in the morning after breakfast. Measurements will be conducted using the InBody 270, a validated bioelectrical impedance analyzer employed in this study to obtain accurate assessments of body weight, body mass index (BMI), waist-hip ratio, and visceral fat levels. The device offers segmental analysis and visceral fat estimation through non-invasive, standardized procedures, ensuring consistency and reliability in longitudinal tracking.

Detailed description

Background: Overweight and obesity have become major public health challengesdisproportionately affecting adult women worldwide, including Pakistan. Functional foodsare gaining attention for their preventive and therapeutic potential, with Sea buckthornemerging as a promising option due to its rich bioactive composition which exhibit antioxidant, anti-inflammatory, and lipid-regulating properties. This research, therefore, seeks to evaluate the effects of sea buckthorn consumption on female body composition, exploring its role as a nutritional intervention for weight management and metabolic health. Hypothesis: Participants consuming sea buckthorn aqueous infusion showsignificant declines in BMI, body weight, visceral fat, and waist-hip ratio. Methodology : A total of 60 overweight women (BMI 25-29.9 kg/m²), aged 18-50years, will be enrolled and will be randomly allocated to intervention and control groups. Theintervention group will consume freshly prepared seabuckthorn aqueous infusion dailyfor12 weeks, while controls maintain usual habits without supplementation. Data analysis : Data will be analyzed using SPSS version 25. Baseline characteristicsbetween groups will be compared using Descriptive statistics (mean ± SD) as appropriate. Between-group comparisons differences will be analyzed using ANOVA. Statistical significance will be set at p \< 0.05. Outcome : Supplementation with seabuckthorn aqueous infusion over a 12-weekperiodwill result in notable improvements in body composition measures among overweight female adults.

Interventions

DIETARY_SUPPLEMENTSea buckthorn aqueous infusion

Sea buckthorn aqueous infusion prepared by using 5g powder in 250 ml water.

Sponsors

University of Veterinary and Animal Sciences, Lahore - Pakistan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be randomly assigned into two groups in a 1: 1 ratio to either the treatment group (sea buckthorn aqueous infusion) or control group (placebo), both groups will be followed concurrently for 12 weeks to assess changes in bmi, body weight, visceral fat and waist-hip ratio.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

females, age 18-50, bmi greater or equal to 25.

Exclusion criteria

current pregnancy or lactation, a history of chronic metabolic or gastrointestinal diseases, use of weight management drugs or supplements, known allergies to sea buckthorn or other documented intolerances, smoking or alcohol consumption, a physical activity level exceeding 1.4, and prior participation in weight loss research programs

Design outcomes

Primary

MeasureTime frameDescription
Body weight12 weeksunit of measurement in kilograms will be measured by weight machine
Body mass indexat the end of intervention (12 week)body mass index will be measured using body mass index calculator

Secondary

MeasureTime frameDescription
visceral fatat the end of intervention period (12 week)visceral fat will be measured using bioelectric impedance analysis
waist-hip ratioat the end of intervention period ( 12 week)waist hip ratio will be measured using measuring tape

Countries

Pakistan

Contacts

Primary ContactEesha Naeem, Post graduate
eeshanaeem22@gamil.com+923264095787
Backup ContactDr. Qaisar Raza, Phd
qaisar.raza@uvas.edu.pk+923002479044

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026